adenosine has been researched along with Demyelinating Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fang, Z; Huang, Q; Kong, J; Xu, H; Yang, L; Zhang, J | 1 |
Bonan, CD; Morsch, VM; Schetinger, MR; Wyse, AT | 1 |
Asghari, AA; Azarnia, M; Javan, M; Mirnajafi-Zadeh, J | 1 |
1 review(s) available for adenosine and Demyelinating Diseases
Article | Year |
---|---|
NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Atherosclerosis; Blood Coagulation; Blood Platelets; Cell Communication; Demyelinating Diseases; Epilepsy; Humans; Metabolism, Inborn Errors; Myocardial Infarction; Neoplasms; Platelet Activation; Platelet Aggregation; Seizures; Signal Transduction; Tamoxifen; Thrombosis | 2007 |
2 other study(ies) available for adenosine and Demyelinating Diseases
Article | Year |
---|---|
Adenosine Promotes the Recovery of Mice from the Cuprizone-Induced Behavioral and Morphological Changes while Effecting on Microglia and Inflammatory Cytokines in the Brain.
Topics: Adenosine; Animals; Behavior, Animal; Brain Chemistry; Cerebral Cortex; Chelating Agents; Cuprizone; Cytokines; Demyelinating Diseases; Dose-Response Relationship, Drug; Gliosis; Hippocampus; Male; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Oligodendroglia; Psychomotor Performance; Schizophrenia | 2018 |
Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Demyelinating Diseases; Disease Models, Animal; Electrophysiological Phenomena; Male; Myelin Sheath; Nerve Regeneration; Neuroprotective Agents; Optic Chiasm; Rats; Rats, Wistar | 2013 |